HOME> PR Center> NEWS
- NDS to select partner for blockchain-based MyData Demonstration Service
NDS(CEO Joongwon Kim) announced that the “personal health coordinator service through direct-to-consumer (DTC) test” project was submitted and finally selected in the 2020 MyData (personal information application support) Demonstration Service support project organized by the Ministry of Science and ICT (MSICT) and Korea Data Agency.
Attempts to strengthen personalized data have been continuously made to combine daily lifelog data with medical data at medical institutes, enhance health, and prevent and manage diseases. However, active use and new business developments were quite challenging given the lack of restrictions or understanding about an individual’s personal medical data use and application area, as well as concerns about privacy invasion by business holders. As such, the company has not progressed further from the initial stages in Korea although new businesses have been actively developed in other countries through DTC tests.
The current business guarantees personal data mobility and exchange within domestic medical institutes that would allow the building of a structure for the new personalized health management market. For its differentiating factor, NDS will apply blockchain-based decentralized identifiers (DIDs) to ensure safe general management and build the medical MyData platform.
With the NDS MyData platform, people would be able to manage their medical information, such as personal genetic analysis information, pharmacy prescriptions, health examination results, and intestinal microbial flora analysis results. When a person decides to provide such information to a medical institute or business company, he/she would be able to receive recommendations on HFF, personalized diagnosis, and insurance services. As such, this would be the real initial stage of a medical information business platform that many medical companies are targeting.
U2Bio and Janwon Medical Institute would participate in the business as companies that hold data, while the Korea Pharmaceutical Information Center (KPIC), Kyobo Life Insurance, and GENE 1on1 are in charge of processing. Moreover, Seoul’s Samsung Medical Center, Chungnam National University Hospital, Nongshim, and Theragene would join as cooperating organizations.
Kim announced that the company aims to “contribute to public health enhancement through the materialization of an advanced IT-based general health-care platform for personalized health management service, smart hospital, electronic prescription, and disease prevention through genetic analysis with the pilot project.”
※ Decentralized Identifier (DID): Personal identification technology controlled by an individual without centralized institutes using blockchain